Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06732193

Fissios© and Postoperative Complications (FPoC Trial)

Respiratory physiotherapy as part of a pre-operative physical training program may reduce the risk of developing post-operative complications, improving post-operative results and optimizing physical conditions in patients with a diagnosis of non-small cell lung cancer (NSCLC) undergoing lung resection surgery. During the post-operative period, performing physical exercise has also been proved to increase the capacity for exercise, improve health-related quality of life and reduce the feeling of breathlessness. Fissios App is a tool created by thoracic surgeons, physiotherapists and a specialist doctor in physical medicine and rehabilitation, which has been satisfactorily implemented in thoracic surgery patients; this contains a program of standardized respiratory physiotherapy exercises with a defined time and number of repetitions.

The aim is to compare the effectiveness of use of the Fissios App tool as a complement to a peri-operative respiratory physiotherapy program compared to just attendance at a face-to-face peri-operative respiratory physiotherapy program, to reduce the incidence of post-operative complications.

It is expected to include 560 patients in the study. Subsequent to evaluation by the investigator and the acceptance of participant to take part in the study, the performing of peri-operative respiratory physiotherapy is prescribed. The participants will be randomly assigned to a study group that uses the tool as a complement to the respiratory physiotherapy program or a control group that should only attend face-to-face respiratory physiotherapy sessions. All the participants should attend face-to-face respiratory physiotherapy classes taught by physiotherapists at the place and time set out in each centre before and after surgery for at least 45 minutes and at least five sessions. Moreover, study group participants may use the Fissios App tool. Investigators should fill in the pre-operative, surgery and post-operative data for each patient on the Fissios Research platform.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Surgical Procedure, Unspecified Bronchial Neoplasms Carcinoma, Bronchogenic Carcinoma, Non-Small-Cell Lung Lung Diseases Lung Neoplasms Neoplasms Neoplasms by Site Non Small Cell Lung Cancer Pathologic Processes Pathological Conditions, Signs and Symptoms Perioperative Care Postoperative Complications Respiratory Tract Diseases Respiratory Tract Neoplasms Surgery Scheduled Thoracic Neoplasms Thoracic Surgery

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Hospital Clínico San Carlos

Madrid, 28040, Spain

Location status: Recruiting

Location contact

Carlos Alfredo Fraile Olivero, PhD

CONTACT

[email protected]

+34917043708

Carlos Alfredo Fraile Olivero, PhD

PRINCIPAL_INVESTIGATOR

About this study

The FPoC Trial is designed as a multicentre, prospective, randomised, prospective, parallel, two-group, controlled, open-label, superiority study of only face-to-face respiratory physiotherapy or the use of Fissios App© as an adjunct to respiratory physiotherapy in patients scheduled for lung resection surgery.

The participants who take part in the study will be randomly assigned to the study or control group before the surgical procedure. All of them will follow an in-person respiratory physiotherapy programme, and the study group will complement this programme with the use of the Fissios App tool.

Perioperative care will be carried out in accordance with national and international guidelines. Postoperative complications will be recorded following the established definitions of the European Society of Thoracic Surgeons (ESTS) database and in the study protocol.

Finally, all the participants will be followed up for 90 days after the date of surgery to finalise the present study. The participants will continue the revisions following the protocols of each centre.

An estimated total of 560 particpants (280 per group) will be recruited for this study.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients over 18 years of age.
  • Indication for lung resection surgery due to diagnostic suspicion or histopathological diagnosis of non-small cell lung carcinoma.
  • Anatomical lung resection surgery: anatomical segmental resection, lobectomies or pneumonectomies, using a conventional or minimally invasive approach (VATS, RATS).
  • The patient has a smart mobile device compatible with the Fissios App©, has the ability or has the support to use it.
  • Willingness and commitment to participate in the study.
  • Ability to complete the informed consent to participate in the study.

Exclusion criteria

  • Medical contraindication to perform respiratory physiotherapy exercises.
  • Not possessing a smart mobile device compatible with Fissios App©.
  • Inability of the patient to perform the exercises, either due to a physical or psychological impediment.
  • Inability to complete the informed consent form for participation in the study.
  • Refusal to participate in the study.

Treatment and study plan

On-site respiratory physiotherapy

Procedure

The patient attends face-to-face physiotherapy sessions prescribed by the doctor.

Fissios App

Device

The patient uses the Fissios App to perform respiratory physiotherapy exercises.

Primary outcomes

  1. Postoperative complications

    Time frame: Through postoperative evolution, an average of 2 weeks.

    Development of at least one adverse clinical event categorised as a postoperative complication during hospital admission. Immediately after the surgery until discharge.

Secondary outcomes

  1. Duration of pleural drainage

    Time frame: Through postoperative evolution, an average of 2 weeks.

    Time that the patient has pleural drainage from the end of surgery until medical discharge.

  2. Mortality

    Time frame: During hospitalization period, an average of 2 weeks.

    Patient status at the moment of discharge.

  3. Hospital readmission

    Time frame: Within 30 days of discharge from hospital

    Any clinical situation requiring hospital admission

  4. Mortality

    Time frame: During the first 30 days after surgery

  5. Mortality

    Time frame: During the first 90 days after surgery

Study contacts

Contact information is provided by the study sponsor or research team.

Carlos A Fraile Olivero, MD, PhD

CONTACT

[email protected]

+34917043708

Lidia Sotillo, MD

CONTACT

[email protected]

+34917043717

Sponsors and collaborators

Lead sponsor

Carlos Alfredo Fraile Olivero, MD, PhD.

Other

Collaborators

  • Asociación Española de Afectados de Cáncer de Pulmón (AEACaP)
  • Medtronic General Research Grant
  • Spanish Society of Pneumology and Thoracic Surgery
  • Spanish Society of Thoracic Surgery (SECT)

Registry information

Official study title

Clinical Trial Comparing a Face-to-face Perioperative Respiratory Physiotherapy Program Versus the Use of Fissios App© as a Complement to a Respiratory Physiotherapy Program in Patients Diagnosed With NSCLC Undergoing Surgery.

Acronym: FPoC

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Dec 13, 2024
Registry last updated
Sep 11, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.